Fuseler JW et al. |
FK506 attenuates developing and established joint inflammation and suppresses interleukin 6 and nitric oxide expression in bacterial cell wall induced polyarthritis. |
2000 |
J. Rheumatol. |
pmid:10648038
|
Bekersky I et al. |
Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg. |
1999 |
Clin Ther |
pmid:10645753
|
Richter-Hintz D et al. |
Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. |
2000 |
J. Am. Acad. Dermatol. |
pmid:10642695
|
Lipper GM et al. |
Recent therapeutic advances in dermatology. |
2000 |
JAMA |
pmid:10634322
|
Thiers BH |
Topical tacrolimus: treatment failure in a patient with alopecia areata. |
2000 |
Arch Dermatol |
pmid:10632221
|
Furutani M et al. |
FK506 binding protein from a thermophilic archaeon, Methanococcus thermolithotrophicus, has chaperone-like activity in vitro. |
2000 |
Biochemistry |
pmid:10631007
|
Wang-Fan W et al. |
Application of centrifugal counter-current chromatography to the separation of macrolide antibiotic analogues. I. Selection of solvent systems based on solubility and partition coefficient investigations. |
1999 |
J Chromatogr A |
pmid:10630872
|
Vanrenterghem YF |
Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine? |
1999 |
Curr. Opin. Nephrol. Hypertens. |
pmid:10630811
|
Paul LC |
Dialysis and transplantation. |
1999 |
Curr. Opin. Nephrol. Hypertens. |
pmid:10630810
|
Haines DD et al. |
Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. |
2000 |
J. Cardiovasc. Pharmacol. |
pmid:10630731
|
Shapiro R et al. |
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10628763
|
Mehta P et al. |
Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10627642
|
Patella V et al. |
HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. |
2000 |
J. Immunol. |
pmid:10623799
|
Uchino T et al. |
Effect of FK 506 and lipo prostaglandin E1 on heart allograft survival in rats. |
1999 |
Scand. Cardiovasc. J. |
pmid:10622549
|
Hashii M et al. |
cADP-ribose potentiates cytosolic Ca2+ elevation and Ca2+ entry via L-type voltage-activated Ca2+ channels in NG108-15 neuronal cells. |
2000 |
Biochem. J. |
pmid:10620496
|
Hida H et al. |
Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats. |
1999 |
Neurosci. Res. |
pmid:10616914
|
Land W |
Mycophenolate mofetil-based immunosuppressive therapy: induction, maintenance, and conversion protocols in renal transplantation. |
1999 |
Transplant. Proc. |
pmid:10616558
|
Gaston RS |
Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens. |
1999 |
Transplant. Proc. |
pmid:10616556
|
Kindt MV et al. |
Tacrolimus toxicity in rhesus monkey: model for clinical side effects. |
1999 |
Transplant. Proc. |
pmid:10616519
|
Charco R et al. |
CD28 regulation in liver transplant recipients treated with two different immunosuppressive regimens. |
1999 |
Transplant. Proc. |
pmid:10616508
|
van Hooff JP and Christiaans MH |
Use of tacrolimus in renal transplantation. |
1999 |
Transplant. Proc. |
pmid:10616483
|
Crétolle-Vastel C et al. |
[Role of calcineurin-dependent drugs on the immunosuppressive effect induced by the anti-LFA-1 antibody in a fetal intestinal transplantation model in mice]. |
1999 |
Chirurgie |
pmid:10615777
|
Bitker MO et al. |
[Combined renal and pancreas transplantation as treatment for chronic renal insufficiency of diabetic origin: a series of 50 consecutive transplantations]. |
1999 |
Chirurgie |
pmid:10615774
|
Yen MT et al. |
Oscillopsia and pseudonystagmus in kidney transplant patients. |
1999 |
Am. J. Ophthalmol. |
pmid:10612521
|
Freudenberger R et al. |
Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathy. |
1999 |
J. Heart Lung Transplant. |
pmid:10612383
|
Olyaei AJ et al. |
Immunosuppressant-induced nephropathy: pathophysiology, incidence and management. |
1999 |
Drug Saf |
pmid:10612271
|
Qi Z et al. |
Malononitrilamides and tacrolimus additively prevent acute rejection in rat cardiac allografts. |
1999 |
Transpl. Immunol. |
pmid:10608300
|
Wright DC et al. |
A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents. |
1999 |
Transpl. Immunol. |
pmid:10608297
|
MacFarlane GD et al. |
Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function. |
1999 |
Ther Drug Monit |
pmid:10604816
|
Bers DM et al. |
Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes. |
1998 |
Ann. N. Y. Acad. Sci. |
pmid:10603944
|
Xu L et al. |
Potential for pharmacology of ryanodine receptor/calcium release channels. |
1998 |
Ann. N. Y. Acad. Sci. |
pmid:10603942
|
Briggs CJ et al. |
Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1. |
1999 |
Arch. Virol. |
pmid:10603169
|
Camacho R et al. |
Hypothemycin inhibits the proliferative response and modulates the production of cytokines during T cell activation. |
1999 |
Immunopharmacology |
pmid:10598882
|
Shimoyama M et al. |
Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. |
1999 |
Circulation |
pmid:10595959
|
Yamashita N et al. |
Nuclear factor kappa B mediates interleukin-8 production in eosinophils. |
1999 |
Int. Arch. Allergy Immunol. |
pmid:10592469
|
Dickenmann MJ et al. |
Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia. |
1999 |
Transplantation |
pmid:10589963
|
Batten P et al. |
Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. |
1999 |
Transplantation |
pmid:10589954
|
Fernandez LA et al. |
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. |
1999 |
Transplantation |
pmid:10589951
|
Maes BD et al. |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. |
1999 |
Transplantation |
pmid:10589943
|
von Baum H et al. |
Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group. |
1999 |
Clin. Infect. Dis. |
pmid:10589909
|
Agarwala S et al. |
Co-administration of co-trimoxazole does not augment tacrolimus-induced impairment in kidney function in rats. |
1999 |
Ren Fail |
pmid:10586426
|
Tsuchida M et al. |
T cell activation up-regulates the expression of the focal adhesion kinase Pyk2: opposing roles for the activation of protein kinase C and the increase in intracellular Ca2+. |
1999 |
J. Immunol. |
pmid:10586059
|
Miyamoto S and Safer B |
Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation. |
1999 |
Biochem. J. |
pmid:10585867
|
Le Bricon T et al. |
Changes in plasma cystatin C after renal transplantation and acute rejection in adults. |
1999 |
Clin. Chem. |
pmid:10585359
|
Wong TY et al. |
Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. |
1999 |
Am. J. Kidney Dis. |
pmid:10585325
|
Busque S et al. |
[Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus]. |
1999 |
Ann Chir |
pmid:10584376
|
Horigome A et al. |
Lymphocyte-sensitivity to glucocorticoid correlates with the sensitivity to cyclosporin A and tacrolimus in chronic renal failure patients. |
1999 |
Br J Clin Pharmacol |
pmid:10583028
|
Mathieu P et al. |
Conversion of cyclosporine A to tacrolimus following heart transplantation. |
1999 |
Can J Cardiol |
pmid:10579737
|
Lowry PW et al. |
Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae. |
1999 |
Inflamm. Bowel Dis. |
pmid:10579116
|
Bush WW |
Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. |
1999 |
AACN Clin Issues |
pmid:10578712
|
Ushigome H et al. |
Two cases of tacrolimus-induced alopecia following kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10578326
|
Manu MA et al. |
Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression. |
1999 |
Transplant. Proc. |
pmid:10578313
|
Uchida H et al. |
Experimental intestinal transplantation using mouse fetal intestine in the rat: combination effect of FK 506 with cyclophosphamide. |
1999 |
Transplant. Proc. |
pmid:10578297
|
Antoniou EA et al. |
Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation. |
1999 |
Transplant. Proc. |
pmid:10578296
|
Azuma T et al. |
Study of graft-infiltrating cells in the rat small bowel allograft using low-dose FK 506. |
1999 |
Transplant. Proc. |
pmid:10578293
|
Kita J et al. |
Effects of tacrolimus on small and large bowel anastomoses in the rat. |
1999 |
Transplant. Proc. |
pmid:10578292
|
Tamura A et al. |
Combination effect of tacrolimus and FTY720 in liver transplantation in rats. |
1999 |
Transplant. Proc. |
pmid:10578290
|
Hairhara Y et al. |
Effect of fluconazole on blood levels of tacrolimus. |
1999 |
Transplant. Proc. |
pmid:10578284
|
Tojimbara T et al. |
Oral vs intravenous tacrolimus-based induction therapy in renal transplantation. |
1999 |
Transplant. Proc. |
pmid:10578282
|
Ishibashi M et al. |
Elimination of the adverse effects of tacrolimus-based induction therapy by a 5-day exposure of optimal steady-state blood concentration in renal transplant patients in the early postoperative period. |
1999 |
Transplant. Proc. |
pmid:10578281
|
Hampel G et al. |
Different effects of cyclosporine and tacrolimus on the activation of mesangial metalloproteinases and their inhibitors. |
1999 |
Transplant. Proc. |
pmid:10578279
|
Moffatt SD et al. |
Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies. |
1999 |
Transplant. Proc. |
pmid:10578277
|
Uchida H et al. |
Chronopharmacology of tacrolimus in rats: toxicity and efficacy in a mouse-to-rat intestinal transplant model and its pharmacokinetic profile. |
1999 |
Transplant. Proc. |
pmid:10578276
|
Sawai T et al. |
A successful induction of tolerance by perioperative intrathymic injection in rat "high-responder" heart transplantation. |
1999 |
Transplant. Proc. |
pmid:10578275
|
Moffatt SD and Metcalfe SM |
FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies. |
1999 |
Transplant. Proc. |
pmid:10578271
|
Fukushima N et al. |
Role of endothelial apoptosis in delayed xenograft rejection in pig-to-baboon cardiac transplantation. |
1999 |
Transplant. Proc. |
pmid:10578268
|
Watanabe Y et al. |
The expression of nonmuscle myosin heavy chain in rat renal transplantation. |
1999 |
Transplant. Proc. |
pmid:10578260
|
Przepiorka D et al. |
Practical considerations in the use of tacrolimus for allogeneic marrow transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10578154
|
Villaverde V et al. |
Leg bone pain syndrome in a kidney transplant patient treated with tacrolimus (FK506) |
1999 |
Ann. Rheum. Dis. |
pmid:10577370
|
Vanrenterghem Y |
Vascular rejection with tacrolimus and potential long-term graft outcome. |
1999 |
Transplant. Proc. |
pmid:10576054
|
Woodle ES et al. |
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. |
1999 |
Transplant. Proc. |
pmid:10576053
|
Jordan ML et al. |
Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. |
1999 |
Transplant. Proc. |
pmid:10576052
|
Morales JM et al. |
Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid. |
1999 |
Transplant. Proc. |
pmid:10576051
|
Squifflet JP et al. |
The Benelux experience with the combination of tacrolimus and mycophenolate mofetil. |
1999 |
Transplant. Proc. |
pmid:10576050
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Jurewicz WA |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report. |
1999 |
Transplant. Proc. |
pmid:10576048
|
Oliveira DB and Chang R |
Report of the first 118 tacrolimus-treated patients at St George's Hospital, London. |
1999 |
Transplant. Proc. |
pmid:10576047
|
van Hooff JP et al. |
Dosing and management guidelines for tacrolimus in renal transplant patients. |
1999 |
Transplant. Proc. |
pmid:10576046
|
Soriano S et al. |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576045
|
van Hooff JP et al. |
Tacrolimus and glucose metabolism. |
1999 |
Transplant. Proc. |
pmid:10576044
|
Kohnle M et al. |
Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia. |
1999 |
Transplant. Proc. |
pmid:10576043
|
Friemann S et al. |
Conversion to tacrolimus in hyperlipidemic patients. |
1999 |
Transplant. Proc. |
pmid:10576042
|
Kliem V et al. |
Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576041
|
Jordan ML et al. |
Tacrolimus-based immunosuppression in pediatric renal transplantation. |
1999 |
Transplant. Proc. |
pmid:10576039
|
Mayer AD |
Four-year follow-up of the European Tacrolimus Multicenter Renal Study. |
1999 |
Transplant. Proc. |
pmid:10576038
|
Undre NA et al. |
Pharmacokinetics of tacrolimus: clinically relevant aspects. |
1999 |
Transplant. Proc. |
pmid:10576037
|
Zhang Y et al. |
Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites. |
1999 |
J. Biol. Chem. |
pmid:10574930
|
Rao SK et al. |
Limbal allografting using FK-506. |
1999 |
Br J Ophthalmol |
pmid:10574824
|
Young AL et al. |
Allo-limbal transplantation in patients with limbal stem cell deficiency. |
1999 |
Br J Ophthalmol |
pmid:10574823
|
Burke GW et al. |
Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. |
1999 |
Transplantation |
pmid:10573073
|
Shiratori T et al. |
[Immunosuppressive treatment of ulcerative colitis]. |
1999 |
Nippon Rinsho |
pmid:10572417
|
Fujiki M et al. |
Role of T cells in bronchoalveolar space in the development of interstitial pneumonia induced by superantigen in autoimmune-prone mice. |
1999 |
Am. J. Respir. Cell Mol. Biol. |
pmid:10572064
|
Asai A et al. |
High level calcineurin activity predisposes neuronal cells to apoptosis. |
1999 |
J. Biol. Chem. |
pmid:10567426
|
Shaw LM et al. |
Current opinions on therapeutic drug monitoring of immunosuppressive drugs. |
1999 |
Clin Ther |
pmid:10566561
|
Fansa H et al. |
[Stimulation of Schwann cell growth and axon regeneration of peripheral nerves by the immunosuppressive drug FK 506]. |
1999 |
Handchir Mikrochir Plast Chir |
pmid:10566134
|
Müschen A et al. |
Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes. |
1999 |
Inflamm. Res. |
pmid:10563471
|
Myers JN et al. |
Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome. |
1999 |
J. Heart Lung Transplant. |
pmid:10561115
|
Gremillion RB et al. |
Tacrolimus (FK506) in the treatment of severe, refractory rheumatoid arthritis: initial experience in 12 patients. |
1999 |
J. Rheumatol. |
pmid:10555886
|
Reichert TE et al. |
The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines. |
1999 |
Br. J. Cancer |
pmid:10555752
|
Mizuta K et al. |
Influence of tacrolimus on bile acid and lipid composition in continuously drained bile using a rat model. Comparative study with cyclosporine. |
1999 |
Transpl. Int. |
pmid:10551996
|